CPO-401

N/A

Report date: 2024/09/03 16:39:24

Base Information

Drug NameCPO-401
Drug Alias NameCPO401CPO-401
ClassificationBiologics
Mechanisms of ActionS-adenosylmethionine synthase isoform type-2 inhibitors
TargetsS-adenosylmethionine synthase isoform type-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConjupro Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesConjupro Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A